Synapse - BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation

BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation Research Letter

Authors:	Stuver, R.; Mian, A.; Brown, S.; Devlin, S.; Caimi, P. F.; Chinapen, S.; Dahi, P.; Dean, R.; Epstein-Peterson, Z. D.; Hill, B.; Horwitz, S. M.; Lahoud, O.; Lin, R.; Moskowitz, A. J.; Sauter, C.; Shah, G.; Winter, A.; Jagadeesh, D.; Scordo, M.
Title:	BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation
Keywords:	adult; aged; middle aged; overall survival; busulfan; prednisone; doxorubicin; comparative study; cytarabine; cancer staging; follow up; antineoplastic agent; letter; progression free survival; etoposide; antineoplastic combined chemotherapy protocols; cyclophosphamide; melphalan; vincristine; hematopoietic stem cell transplantation; histology; carmustine; length of stay; peripheral t cell lymphoma; t cell lymphoma; transplantation conditioning; remission; multivariate analysis; transplantation, autologous; autologous hematopoietic stem cell transplantation; pharmacokinetics; platelet count; non-hodgkin lymphoma; international prognostic index; lymphoma, t-cell, peripheral; autotransplantation; procedures; brentuximab vedotin; humans; human; male; female; tumor necrosis factor receptor superfamily member 8
Journal Title:	American Journal of Hematology
Volume:	99
Issue:	6
ISSN:	0361-8609
Publisher:	John Wiley & Sons, Inc.
Date Published:	2024-06-01
Start Page:	1180
End Page:	1183
Language:	English
DOI:	10.1002/ajh.27291
PUBMED:	38526002
PROVIDER:	scopus
PMCID:	PMC11096040
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85189205592&doi=10.1002%2fajh.27291&partnerID=40&md5=be2c0e583d0418e56f9581bb05cba9e7
Notes:	The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Corresponding author is MSK author: Robert Stuver -- Source: Scopus